APOE and Alzheimer disease: While entorhinal hindered diffusion was lower and hippocampal free water was higher for cognitively impaired participants across the full sample, these differences were accentuated among APOE4 carriers, consistent with their role as preclinical targets of AD neuropathology and neurodegeneration.